![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 29, 26983-26991, July 18, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 and
3 Integrins Promote T Cell Receptor-mediated Cytotoxic T Lymphocyte Activation*
From the aInstitute for Biochemistry, University of Lausanne, 1066 Epalinges, Switzerland, the dLudwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, 1066 Epalinges, Switzerland, cINSERM U563, CHU Purpan, 31059 Toulouse, France, the eKantonsspital, University of Basel, 4031 Basel, Switzerland, and the fCentre Pluridisciplinaire d'Oncologie, University of Lausanne Medical School, 1066 Epalinges, Switzerland
Recognition by CD8+ cytotoxic T lymphocytes (CTLs) of antigenic
peptides bound to major histocompatibility class (MHC) I molecules on target
cells leads to sustained calcium mobilization and CTL degranulation resulting
in perforin-dependent killing. We report that
1 and
3 integrin-mediated adhesion to extracellular matrix proteins
on target cells and/or surfaces dramatically promotes CTL degranulation. CTLs,
when adhered to fibronectin but not CTL in suspension, efficiently degranulate
upon exposure to soluble MHC·peptide complexes, even monomeric ones.
This adhesion induces recruitment and activation of the focal adhesion kinase
Pyk2, the cytoskeleton linker paxillin, and the Src kinases Lck and Fyn in the
contact site. The T cell receptor, by association with Pyk2, becomes part of
this adhesion-induced activation cluster, which greatly increases its
signaling.
Received for publication, March 17, 2003 , and in revised form, April 9, 2003.
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
g Supported by grants from La Ligue contre le Cancer, l'Association de la Recherche contre le Cancer, and la Fondation pour la Recherche Médicale.
h Supported by a grant of the Gabriella Giorgi-Cavaglieri Foundation and by the Swiss National Science Foundation (Grant 31-061960.00).
i Supported by the Swiss National Science Foundation (Grant 3100-061946.00).
b To whom correspondence should be addressed. Tel.: 41-21-692-5745; Fax: 41-21-692-5705; E-mail: ma_doucey{at}hotmail.com.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Kanamori, T. Kawaguchi, M. S. Berger, and R. O. Pieper Intracranial Microenvironment Reveals Independent Opposing Functions of Host {alpha}Vbeta3 Expression on Glioma Growth and Angiogenesis J. Biol. Chem., December 1, 2006; 281(48): 37256 - 37264. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Angelov, P. Guillaume, M. Cebecauer, G. Bosshard, D. Dojcinovic, P. Baumgaertner, and I. F. Luescher Soluble MHC-Peptide Complexes Containing Long Rigid Linkers Abolish CTL-Mediated Cytotoxicity J. Immunol., March 15, 2006; 176(6): 3356 - 3365. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Buzza, L. Zamurs, J. Sun, C. H. Bird, A. I. Smith, J. A. Trapani, C. J. Froelich, E. C. Nice, and P. I. Bird Extracellular Matrix Remodeling by Human Granzyme B via Cleavage of Vitronectin, Fibronectin, and Laminin J. Biol. Chem., June 24, 2005; 280(25): 23549 - 23558. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cebecauer, P. Guillaume, S. Mark, O. Michielin, N. Boucheron, M. Bezard, B. H. Meyer, J.-M. Segura, H. Vogel, and I. F. Luescher CD8+ Cytotoxic T Lymphocyte Activation by Soluble Major Histocompatibility Complex-Peptide Dimers J. Biol. Chem., June 24, 2005; 280(25): 23820 - 23828. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cebecauer, P. Guillaume, P. Hozak, S. Mark, H. Everett, P. Schneider, and I. F. Luescher Soluble MHC-Peptide Complexes Induce Rapid Death of CD8+ CTL J. Immunol., June 1, 2005; 174(11): 6809 - 6819. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Butler and S. D. Blystone Tyrosine Phosphorylation of {beta}3 Integrin Provides a Binding Site for Pyk2 J. Biol. Chem., April 15, 2005; 280(15): 14556 - 14562. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sipione, C. Ewen, I. Shostak, M. Michalak, and R. C. Bleackley Impaired Cytolytic Activity in Calreticulin-Deficient CTLs J. Immunol., March 15, 2005; 174(6): 3212 - 3219. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Brown and C. E. Turner Paxillin: Adapting to Change Physiol Rev, October 1, 2004; 84(4): 1315 - 1339. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. McLeod, A. J. Shum, R. L. Lee, F. Takei, and M. R. Gold The Rap GTPases Regulate Integrin-mediated Adhesion, Cell Spreading, Actin Polymerization, and Pyk2 Tyrosine Phosphorylation in B Lymphocytes J. Biol. Chem., March 26, 2004; 279(13): 12009 - 12019. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wooldridge, S. L. Hutchinson, E. M. Choi, A. Lissina, E. Jones, F. Mirza, P. R. Dunbar, D. A. Price, V. Cerundolo, and A. K. Sewell Anti-CD8 Antibodies Can Inhibit or Enhance Peptide-MHC Class I (pMHCI) Multimer Binding: This Is Paralleled by Their Effects on CTL Activation and Occurs in the Absence of an Interaction between pMHCI and CD8 on the Cell Surface J. Immunol., December 15, 2003; 171(12): 6650 - 6660. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |